Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07527741) titled 'A Study to Assess Treatment Patterns and Treatment Adherence in Early HER2-positive Breast Cancer Participants After Treatment Decentralization' on April 7.

Study Type: Observational

Primary Sponsor: Hoffmann-La Roche

Condition: Early-stage HER2+ Breast Cancer

Recruitment Status: Recruiting

Date of First Enrollment: February 23, 2026

Target Sample Size: 100

Countries of Recruitment: Serbia

To know more, visit https://clinicaltrials.gov/study/NCT07527741

Published by HT Digital Content Services with permission from Health Daily Digest....